Drug treatment of chemotherapy-induced delayed emesis (Q41445456)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 1996

edit

Language	Label	Description	Also known as
English	Drug treatment of chemotherapy-induced delayed emesis	scientific article published on November 1996

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Drug treatment of chemotherapy-induced delayed emesis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

main subject

chemotherapy

1 reference

based on heuristic

inferred from title

author name string

R Tavorath

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

P J Hesketh

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

publication date

1 November 1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

volume

52

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

page(s)

639-648

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

cites work

High-dose dexamethasone for prevention of cis-platin-induced vomiting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of chemotherapy-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Em

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small intestinal mucosal toxicity of cis-platinum--comparison of toxicity with platinum analogues and dexamethasone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Natural Course of Emesis After Carboplatin Treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomized trial for the control of delayed emesis in patients receiving cisplatin: comparison of placebo vs. adrenocorticotropic hormone (ACTH)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Instit

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammalian Tachykinin Receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The course of nausea and vomiting after high-dose cyclophosphamide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional and structural changes of the human proximal small intestine after cytotoxic therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin-induced emesis in the Ferret: a new animal model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9118814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003495-199652050-00002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

Dimensions Publication ID

1037308623

0 references

PubMed publication ID

9118814

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9118814

retrieved

30 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41445456&oldid=2204541721"